Prot#APD371-004: A Randomized, Open-label, Parallel, Phase 2a Study to Determine the Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects with Crohn’s Disease Experiencing Abdominal Pain

Project: Research project

Project Details

StatusFinished
Effective start/end date3/29/18 → 3/29/21

Funding

  • PPD Investigator Services, LLC (Prot#APD371-004 // Prot#APD371-004)
  • Arena Pharmaceuticals, Inc. (Prot#APD371-004 // Prot#APD371-004)